Zomedica (AMEX: ZOM)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.004 | ||||||
REV | 3.751M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Zomedica (AMEX: ZOM) through any online brokerage.
There are no as such competitors for Zomedica.
The latest price target for Zomedica (AMEX: ZOM) was reported by HC Wainwright & Co. on Monday, November 16, 2020. The analyst firm set a price target for 0.30 expecting ZOM to rise to within 12 months (a possible 44.09% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Zomedica (AMEX: ZOM) is $0.2082 last updated July 1, 2022, 7:59 PM UTC.
There are no upcoming dividends for Zomedica.
Zomedica’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Zomedica.
Zomedica is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the AMEX.